Sensei Biotherapeutics Inc (SNSE) — Financial Flexibility Index
Sensei Biotherapeutics Inc (SNSE) has a Financial Flexibility Index of -0.90x as of December 2025. Free cash flow of $-3.86 Million (operating CF $-3.86 Million minus capex $0.00) represents -1% of total liabilities ($4.31 Million). Also explore Sensei Biotherapeutics Inc (SNSE) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sensei Biotherapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Sensei Biotherapeutics Inc across 8 annual periods. Check Sensei Biotherapeutics Inc (SNSE) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sensei Biotherapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Sensei Biotherapeutics Inc. For the full company profile including market capitalisation, see SNSE market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.74x | $-20.44 Million | $-20.45 Million | $4.31 Million | ▼ -34.9% |
| 2024 | -3.52x | $-24.52 Million | $-24.67 Million | $6.97 Million | ▼ -4.7% |
| 2023 | -3.36x | $-31.84 Million | $-32.02 Million | $9.48 Million | ▼ -29.9% |
| 2022 | -2.59x | $-38.70 Million | $-39.03 Million | $14.97 Million | ▲ +38.5% |
| 2021 | -4.21x | $-28.23 Million | $-30.26 Million | $6.71 Million | ▼ -41.1% |
| 2020 | -2.98x | $-16.50 Million | $-17.70 Million | $5.54 Million | ▼ -2345.4% |
| 2019 | -0.12x | $-8.52 Million | $-8.57 Million | $69.88 Million | ▲ +34.4% |
| 2018 | -0.19x | $-10.28 Million | $-10.31 Million | $55.33 Million | — |